Abstract. This study deals with the interaction of polypeptide hormones with their receptors. Specifically it involves the binding of synthetic ACTH analogs and fragments to a particulate fraction from beef adrenal cortical tissue. This fraction was found to bind synthetic [Gln5]f-corticotropini-2o amide but failed to bind significant 'amounts of [Gln6]B3-corticotropin1l1o. 13-corticotropin1-2o amide from the particulate fraction a significant correlation between binding and in vivo adrenocorticotropic activity was established. Major "active" and "binding" sites were shown to reside in different sections of the ACTH molecule. Charged groups play a major role in the attachment of ACTH to the particulate fraction and the sequence Lys-Lys-Arg-Arg proved to be particularly significant. The high degree of binding specificity for ACTH peptides which is exhibited by the particulate suggests that it contains ACTH receptor(s). Moreover, the striking similarity between observations with the S-peptide-S-protein model system'and the system described would seem to indicate that the ACTH receptor is a protein.
13-corticotropin1-2o amide from the particulate fraction a significant correlation between binding and in vivo adrenocorticotropic activity was established. Major "active" and "binding" sites were shown to reside in different sections of the ACTH molecule. Charged groups play a major role in the attachment of ACTH to the particulate fraction and the sequence Lys-Lys-Arg-Arg proved to be particularly significant. The high degree of binding specificity for ACTH peptides which is exhibited by the particulate suggests that it contains ACTH receptor(s). Moreover, the striking similarity between observations with the S-peptide-S-protein model system'and the system described would seem to indicate that the ACTH receptor is a protein.
It is generally accepted that the initial event in hormone action involves a stereospecific combination between the hormone and a "receptor" and that this "sticking" initiates the sequence of events which result in the characteristic physiological effect. Although the covalent structures of a great number of hormones are known, the true chemical nature of hormone "receptors" is obscure. Synthetic manipulatiop of a given hormone and evaluation of the effect of such manipulation on its ability to bring about the physiological response of the parent compound is a method which has been employed to gain insight into the structural features which are essential for function. In certain instances these structure-function studies have shown that only a section of the total hormone molecule is essential for biological activity. A typical example is the adrenocorticotropic hormone ACTH, which consists of a single peptide chain 829 amide) which corresponds to the N-terminal section of ACTH was shown to possess the full in vivo steroidogenic potency of the intact hormone."3 This segment of the hormone molecule must contain the structural features which are responsible for its attachment to the receptor and those which are intimately connected with biological activity.
Unquestionably, results derived from structure-function studies with homogeneous synthetic fragments and analogs of ACTH can provide significant information about the function of the total molecule. However, a more meaningful interpretation of such observations with ACTH and other polypeptide hormones appears to depend on the discovery of in vitro test systems which will allow differentiation between binding and function. (500 ml). The tissue was homogenized in a Dounce homogenizer with a loosely fitting pestle, the volume of the homogenat0 was adjusted to 2000 ml by addition of 0.001 M NaHCO3, and the suspension was stirred for 5 min and filtered through glass wool. The filtrate was centrifuged at 2000 X g and the pellet was washed as described by Neville6 until the supernate was clear and colorless. The washed pellet was suspended in sucrose d = 1.16 (final volume 16 ml), and aliquots (5 ml each) of this suspension were added to three tubes each containing a discontinuous sucrose gradient consisting of 5 ml of d = 1.30; 8 ml of d = 1.20, and 10 ml of d = 1.18.7 The tubes were centrifuged in a swingingbucket head at 90,000 X g for 120 min and the particles which collected at the interphase between the d = 1.16 and d = 1.18 sucrose layers were removed by suction (volume 8-12 ml) and mixed with 8 ml of 0.001 M NaHCO3. This suspension was used directly for binding studies or was frozen for future use. Repeated freezing or thawing did not alter the binding capacity of the preparation. Particulates from beef liver, kidney, and adrenal medulla were prepared similarly. For determination of protein content the particulates (3 ml) derived from the various tissues were centrifuged for 15 min at 15,000 X g and the supernates were decanted. The pellets were washed with 3 ml of water by suspension and centrifugation and were then suspended in 0.1 N NaOH (3 ml). Sodium dodecyl sulfate (approximately 3 mg) was added, the mixtures were stirred at room temperature until the particulate material had dissolved (approximately 45 min), and protein was determined in suitable aliquots by the method of Lowry et al. 8 Binding studies: The fresh or thawed suspensions were diluted with 0.001 M NaHCO3 to a protein concentration of 100 ,ug/ml and were homogenized in a Dounce homogenizer. The diluted particulate suspension derived from beef adrenal cortex will be referred to as ACPF.
Centrifuge tubes were charged with various proportions of labeled peptides and water to a volume of 1 ml, and ACPF (1 ml) was added to each tube. The tubes were shaken and kept at 0C for 10 min; they were then centrifuged for 30 mill at 20,000 X g and ali- ml of the ACPF as judged by a binding study), a fl-corticotropin analog, and water to a final volume of 1 ml. ACPF (1 ml) was added to each tube; the tubes were shaken, allowed to stand at 0WC for 10 min, and centrifuged for 30 min at 20,000 X g. Radioactivity in 0.5 ml of the supernate was determined as described. Results and Discussion. Lefkow"itz et al. 9 have prepared a soluble extract of mouse adrenal tumor cells which binds [1251]ACTH. Binding was correlated with stimulation of the "ACTH-sensitive adenyl cyclase." Exposure of the ACTH preparation to sodium hydroxide, trypsin, or leucine aminopeptidase or oxidation with periodate largely destroyed binding and cyclase activation.
The observation that ACTH appears to bind to the surface of certain mouse adrenal tumor cells10 stimulated our interest in adrenal cortical plasma membranes as a likely source of ACTH "receptor." As a consequence, we applied techniques developed for isolation of liver plasma membranes6'7 to beef adrenal cortical homogenates and tested the ensuing particulate fraction (ACIJF), which was not homogeneous morphologically, for its ability to bind homogeneous synthetic peptides related to ACTH. Using some of the peptides and peptide fragments whose covalent structure and in vivo steroidogenic activities are shown in Fig. 1 , we performed two types of studies. In the first set of experiments the ability of ['4C-Phe] [Gln5] i3-corticotropini-2o amide (V) to bind to the ACPF was compared to its ability to associate with similarly prepared particulate fractions from beef liver, kidney, and adrenal medulla. The ACPF was found to bind significant amounts of this peptide but particulates derived from the other tissues showed little affinity for the ACTH analog. These results illustrate the tissue specificity of the observed binding.
The ability of the ACPF to bind peptide V was then compared to its affinity for ['4C-Phe] [Gln5] f3-corticotropin-1o (IX). The high affinity for the biologically active peptide V and the poor binding of the biologically inactive peptide IX (Fig. 2) can be interpreted in two ways. Either the binding sites of peptide V are located in the C-terminal region (positions 1-1-20) or the backbone of the complete peptide is essential both for binding and biological activity because of specific conformational requirements. In order to collect additional evidence for the specificity of the binding of V to the ACPF and to clarify other points, competitive displacement experiments were performed. In these studies the ACPF was saturated with the labeled 8-corticotropins-2o derivative (V)1I and increasing proportions of nonradioactive fragments or analogs of f3-corticotropin were added. Plotting the ratios of bound/free radioactivity which remained in the supernate after centrifugation versus the amount of nonradioactive peptide added provided the results shown in Fig. 3 .
The tricosapeptide III, a highly effective steroidogenic agent, displaces radioactive peptide V from the "complex." 11 Approximately 50% of the bound radioactivity is displaced when the mole ratio of ralioactive/nonradioactive peptide is unity. As was to be expected, the two compounds exhibit approximately the same binding affinity for ACPF and appear to compete. for the same site or sites.
The finding that the biologically inactive protected tricosapeptide (IV) fails to displace radioactivity from the complex" suggests that soie or all of the eamino groups of lysines 11, 15, 16, and 21 are involved in the binding process.
Lysine 21 can be eliminated from consideration on the basis of the observation that f-corticotropinht 0 amide2o 3 (which lacks this residue) and peptide III are This concept receives additional support from studies with peptides X, XI, and the 11,15,16-NE-formyllysine derivative of peptide XI, all devoid of adrenocorticotropic activity. Peptide XI, with three free lysines, dissociates the complex" although not as effectively as peptide III. In contrast, the two protected peptides show little affinity for the ACPF. In addition to demonstrating the importance of the lysine residues for binding this experimental result shows clearly that major binding sites of ACTH,-2o are located in the C-terminal region (positions [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] and that charge-charge interactions appear to play a significant role in the binding process.
To eliminate the possibility that the observed binding represents a nonspecific interaction between the ACPF and basic peptides per se the ability of the tetrapeptide arginylarginylprolylvaline amide2'4 (positions [17] [18] [19] [20] to displace radioactivity was investigated. The peptide failed to bind. However, the Arg-ArgPro-Val amide portion must contribute to the association of 3-corticotropini_20 amide with the ACTH receptor(s), since its elimination brings about an almost complete loss of in vivo adrenocorticotropic activity. f3-Corticotropini_16rb exhibits biological activity of the order of 0.1 unit/mg.
The most striking demonstration of the specificity of the ACPF-ACTH interaction is the finding that an equimolar mixture of 0-corticotropin,,16 and ,3-corticotropinl742o amide fails to dissociate the complex"; #-corticotropin,-20 amide differs from the mixture by the presence of an intact peptide bond between residues 16 and 17.
These results verify the hypothesis'2 that the sequence Lys-Lys-Arg-Arg is an important binding site of the ACTH molecule and explain the low biological activity of the hexadecapeptide in terms of poor affinity for the receptor(s). Actually only four positive charges appear to be required at this site since the replacement of the arginines by ornithine residues does not alter the in vivo adrenocorticotropic activity of 0-corticotropin,-24 '3 The methionine residue located in the N-terminal section of the ACTH molecule appears to contribute to binding. Oxidation of the thioether sulfur to the sulfoxide brings about a marked decrease in in vivo adrenocorticotropic activity'4, but substitution of the methionine by a-amino-n-butyric acid"', Nle '6, or Leu'7 results in biologically active analogs. These observations eliminate the thioether sulfur as a functionally active structural element of ACTH and suggest that the low order of activity of the oxidized ACTH is the result of poor binding.
With the S-peptide-S-protein system of ribonuclease S'8, which has served as our model for hormone-receptor interaction, we have observed a strikingly similar behavior of the methionine residue of S-peptide.9" 20 Competitive inhibition experiments were particularly revealing. Ribonuclease S, the enzymically fully active noncovalent combination of equimolar proportions of S-peptide and S- The functionally important or active sites of the ACTH molecule reside in the N-terminal region between positions 1 and 10. This section of the hormone has been the object of extensive structure-function studies and a variety of amino acid replacements were found to be compatible with biological activity. Fig. 3 , peptide VI has the same ability to displace radioactivity from the complex" as does the biologically fully active peptide III, despite the fact that its biological activity is of a very low order indeed (Fig. 1) . We conclude that the role of [Trp9] for biological activity of ACTH cannot be explained in terms of a simple binding contribution. The same appears to be true for [Arg8] (see 23) .
In addition to its adrenal-linked physiological effects, the ACTH molecule exhibits certain extra-adrenal functions such as the ability to expand melanocytesi.e., the property to bring about the darkening of the skin. Two other polypeptide hormones, namely a-and /3-MSH (melanocyte-stimulating hormone), both derived from pituitary tissue, share this property with ACTH. a-MSH is an N-acetyltridecapeptide amide whose amino acid sequence corresponds to that of the first 13 residues of the ACTH molecule. The amino acid sequence of ,3-MSH is different, but all three compounds contain the structural element MetGlu-His-Phe-Arg-Trp-Gly, which appears to provide the key to the skin-darkening effect.26 Peptide VIII is a synthetic derivative of a-MSH in which [Glu5] is replaced by Gln and [Lys"] by Ne-formyllysine. This peptide is fully as active as natural a-MSH as concerns melanocyte expansion but fails to stimulate the adrenal cortex.5a It cannot be a coincidence that peptide VIII is also ineffective in displacing radioactivity from the complex" (Fig. 3) . From this observation we conclude that although a-MSH possesses the "functionally" important features of the ACTH molecule, it fails to stimulate the adrenal cortex because it lacks the essential "binding" sites. Both ACTH and the two melanocyte-expanding hormones must possess common "attachment" sites for melanocytes.
The high degree of binding specificity which has been demonstrated suggests that the ACPF contains an ACTH receptor or receptors. Only speculations can
